1. Home
  2. SHMD vs ARMP Comparison

SHMD vs ARMP Comparison

Compare SHMD & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$5.92

Market Cap

216.2M

Sector

N/A

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$6.31

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHMD
ARMP
Founded
1864
N/A
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.2M
125.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SHMD
ARMP
Price
$5.92
$6.31
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
208.8K
45.6K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$85,165,542.00
$5,054,000.00
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.86
$0.90
52 Week High
$6.70
$16.34

Technical Indicators

Market Signals
Indicator
SHMD
ARMP
Relative Strength Index (RSI) 63.97 56.96
Support Level $4.70 $6.09
Resistance Level $5.40 $6.54
Average True Range (ATR) 0.64 0.53
MACD 0.07 0.04
Stochastic Oscillator 77.36 100.00

Price Performance

Historical Comparison
SHMD
ARMP

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: